Trial intelligence / Profile preview

Combined vs Traditional Prolotherapy for TMJ Hypermobility

NCT07020455Phase 4Completed

Sponsor
Karadeniz Technical University
Start
Jan 2019
Primary completion
Jan 2022
Countries
1
01

Overview

A Phase 4 trial of dextrose in temporomandibular joint hypermobility (TMJH), sponsored by Karadeniz Technical University. Started Jan 2019; status: completed.

02

Drugs

dextrose
03

Conditions

temporomandibular joint hypermobility (TMJH)

Beyond the preview

Go deeper on NCT07020455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07020455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call